Sickle cell gene therapies seen as cost effective below $2M threshold
FDA requires 'boxed warning' for CAR-T cancer therapies
Johnson & Johnson narrowly tops quarterly estimates as pharmaceutical, medtech sales jump
Trial raises hopes for simple Alzheimer’s blood test
